ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CRBU vs ELOX // ENTERPRISE SCALE & MARKET CAP

Caribou Biosciences Inc. (NASDAQ) VS. Eloxx Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: CRBU 1 — ELOX 2
▲ ENTERPRISE SCALE & MARKET CAP LEADER: ELOX
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CRBU VS. ELOX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CRBU ELOX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — -11.87% — TIE /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) 11.70% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 1/9 +3.00 CRBU /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 27.5 45.4 -17.93 ELOX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $47.7M $53.3M -$5.6M ELOX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CRBU REV ELOX REV CRBU GROSS % ELOX GROSS % CRBU FCF ELOX FCF
FY 2025 $11.2M $0 — — -$112.4M -$6.3M
FY 2024 $10.0M $6.4M — — -$143.1M -$4.7M
FY 2023 $34.5M $0 — — -$93.3M -$14.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CRBU // BETA —
ELOX // BETA —